This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive  Media Kit | Clinical Laboratory Marketplace    

Home   About   Scholarships   Meetings   Publications   Resources   Jul. 10, 2012

 



CDC updates Hepatitis B recommendations for infected healthcare workers
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The US Centers for Disease Control and Prevention (CDC) has updated its 1991 recommendations for the management of hepatitis B virus (HBV)-infected healthcare providers and students to prevent HBV transmission. According to the authors, as with the previous guidelines, HBV infection should not disqualify individuals from practicing medicine. More



FDA clears new rapid clinical laboratory test that reduces time-to-answer for bloodstream infections
Dark Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
One of the more challenging diseases to diagnose and treat is septicemia. Traditional microbiology methods typically require two or three days before an accurate diagnosis can be made. Now there is news of a rapid test for bloodstream infections that can allow a hospital clinical laboratory to deliver an answer to physicians in as little as two hours. More

Combination therapy for breast cancer shows promise
Medical News Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A study published in the July issue of Anticancer Research reveals that scientists from Boston University School of Medicine (BUSM) have found an effective combination therapy for breast cancer cells in vitro that can potentially be used for treating different forms of breast cancer, including cancers resistant to chemotherapy as well as other treatments. About 14 to 20 percent of all breast cancer cases are triple negative breast cancer, meaning the cancer cells lack hormone receptors, including the HER-2 receptor, and are generally unresponsive to hormone and herceptin-based therapies. More

Creative Laboratory Products

Based in Indianapolis, we create our products in FDA licensed laboratories to ensure the highest quality possible. We provide fast solutions for customer's individual lipid additives. Click here to learn more.


Home HIV test wins FDA nod
MedPage Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The FDA has approved the OraQuick In-Home HIV Test, making it the first over-the-counter test for HIV infection that gives results directly to the consumer. During a May meeting, an FDA reviewer estimated that about 2.8 million people would use the OraQuick test each year, and that would lead to 45,000 new positive test results and could avert more than 4,000 HIV transmissions in a year. More

HPV vaccine protects even those who skip it
ABC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The vaccine against the human papilloma virus (HPV) is not only effective in decreasing the rate of high risk types of HPV infections in girls and women, but it also shows evidence of bestowing what is known as "herd immunity" – an indirect protection against the virus for those who have not been vaccinated – in a community at large, researchers said. Researchers at the Cincinnati Children's Hospital Medical Center compared HPV infection rates in women who received the HPV vaccine to infection rates in those who had not. More


CellaVision Automates and Standardizes the Manual Differential

CellaVision introduces CellAtlas®, the perfect way to learn the basics of hematology cell morphology. This App for the Apple iPhone and iPod Touch compliments our digital cell morphology portfolio, and is an educational tool to assist in the recognition and classification of blood cells, by utilizing mini-lectures and cell quizzes. More
Triturus - True Open Flexibility
As a leader in fully automated immunoassay testing systems, Grifols USA Diagnostic Division’s premier product, the TRITURUS® ELISA System is an open, fully automated, multi-test and multi-batch immunoassay system. Grifols USA is a major distributor of quality IVD ELISA tests for Infectious Disease, Autoimmune Diseases and many other disease states. Grifols’ Diagnostic products take the complexity out of clinical diagnostic testing.

1-800-379-0957. diaginfo@grifols.com
Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit clevelandcliniclabs.com.


Simple way to avoid severe toxicity from 5-FU and related drugs
Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A simple screening process can identify people who will react badly to the fluoropyrimidine group of chemotherapy drugs, which includes 5-fluorouracil and the related oral products capecitabine (Xeloda), tegafur, and S-1. In some cases, this prescreen is life-saving, say the French researchers who developed the method. More

Scientists reveal how natural systems limit the spread of 'cheating' bacteria
Phys.Org    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In the first field study of its kind researchers at Royal Holloway, University of London and the University of Oxford have investigated the competitive dynamics of pathogenic and non-pathogenic strains of bacteria. Bacteria are increasingly seen as living and interacting in groups and sharing resources such as virulence factors, biofilms, and proteins used to scavenge iron. However as in human societies, this type of cooperation is threatened by "cheaters" that exploit the hard work of others, but fail to contribute themselves. More



Amniotic fluid offers alternative stem cell source
Reuters via Medscape Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Stem cells taken from amniotic fluid can be transformed into a more versatile state similar to embryonic stem cells and may offer an alternative to the medically valuable but controversial cells, scientists said. British researchers said they had succeeded in reprogramming amniotic fluid cells without having to introduce extra genes. More

Micro-Hall detector counts rare CTCs in clinical samples
Genetic & Engineering Science News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Scientists have developed a miniaturized microfluidic chip–based technology that they claim could form the basis of a rapid, POC diagnostics platform for quantitatively measuring rare circulating tumor cells or pathogens in clinical samples. The micro-Hall detector essentially identifies individual target cells labeled with magnetic nanoparticles as they flow through the channels on a microfluidic chip. More


We've teamed up to save you even more on car insurance.

Find out if you're eligible for exclusive GEICO savings by starting a rate quote now – just make sure you select your group affiliation when asked.
MORE
JoinYour Peers

Many employers now require certification because they know that individuals who are certified are committed to their profession and to quality patient care. Learn how we can help!

www.americanmedtech.org


Officials make break in baffling disease killing Cambodian children
CNN    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Health officials say they have made an important discovery in the mystery surrounding the deaths of 64 children in Cambodia. The Institut Pasteur in Cambodia tested samples taken from 24 patients and found 15 had tested positive for Enterovirus Type 71 – a common cause of hand, foot and mouth disease that can also cause severe neurologic complications, mainly in children. More

Fetal genome sequenced without the father's DNA
New Scientist    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Clinicians seeking to pinpoint genetic diseases in developing fetuses may no longer need to know the identity of the father, thanks to a method for sequencing a fetus' genome using just a blood sample drawn from a pregnant woman. More



New cloud-based network aims to advance clinical trials
iHealthBeat    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Database software company Oracle recently launched the Oracle Health Sciences Network, a set of cloud-based applications designed to advance medical research and help recruit participants for clinical trials. The network aims to help drug companies and health systems cull de-identified patient data from electronic health records and other databases to determine whether a healthcare organization has enough patients to participate in a clinical trial. The network eventually could provide an infrastructure to help researchers develop drugs for patients with specific genetic characterizations and compare the effectiveness of different treatments. More

Gladstone scientists identify critical process in stem cell development
University of California San Francisco    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Scientists at the Gladstone Institutes have discovered that environmental factors critically influence the growth of a type of stem cell – called an iPS cell – that is derived from adult skin cells. This discovery offers newfound understanding of how these cells form, while also advancing science closer to stem cell-based therapies to combat disease. More

Expand your career as a Clinical Lab Scientist at UCSF Medical Center.

Opportunities available in San Francisco, CA in various areas - Chemistry, Hematology, Blood Bank, Immunology, Microbiology, Molecular Diagnostics, Bone Marrow Transplant, and Cytogenetics. Apply online or contact Cheryl Hardin at Cheryl.Hardin@ucsfmedctr.org for more information. EOE.


Alabama study shows cystic fibrosis drug should also be tested to treat chronic obstructive pulmonary disease
The Birmingham News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new University of Alabama-Birmingham study suggests that a drug developed to treat cystic fibrosis should also be tested to treat chronic obstructive pulmonary disease. People who have COPD that is associated with chronic bronchitis show a pathology that shares some similarities to patients who have the inherited disease cystic fibrosis. More

World's fastest camera, created by UCLA engineers, used to detect rogue cancer cells
UCLA    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The ability to distinguish and isolate rare cells from among a large population of assorted cells has become increasingly important for the early detection of disease and for monitoring disease treatments. Achieving good statistical accuracy requires an automated, high-throughput instrument that can examine millions of cells in a reasonably short time. A new optical microscope developed by UCLA engineers could make the tough task a whole lot easier. More



Patients seek stem cell compensation
Nature    Share    Share on FacebookTwitterShare on LinkedinE-mail article
In what could be a landmark case, six patients in California are suing one of the world's largest stem cell companies for allegedly misleading them about the effectiveness of its stem cell treatments. While the U.S. Food and Drug Administration and FBI have taken action against stem cell traders and clinicians, this seems to be the first case in which patients are bringing a suit against a prominent company. More
 


ASCLS eNewsBytes

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Bob Kowalski, Content Editor, 469.420.2650   
Contribute news


This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!

Recent issues

July 3, 2012
June 26, 2012
June 19, 2012
June 18, 2012






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063